Ambev S.A. (NYSE:ABEV) is a top stock under $10 to buy now. UBS analyst lowered price target to $2.20 on Aug 20. Q2 2025 results showed 3.4% revenue growth. Normalized profit rose 15.2% to R$2.8327 billion. EBITDA grew 7.6%. ABEV produces, distributes, and sells beverages in Brazil, CAC, and Canada.

The surge in Ambev SA (ABEV) in 2025 is driven by net revenue growth and strong financial performance. The company’s fiscal Q2 results showed growth in revenue per hectoliter and normalized profit. With an increase in EBITDA and all segments delivering growth, ABEV remains an attractive investment option.

Read more at Yahoo Finance: UBS Lowers PT on Ambev S.A. (ABEV) to $2.20 from $2.50, Keeps a Neutral Rating